Monro Muffler Brake (MNRO) Stake Held by Akre Capital Management Llc; National Planning Decreased Holding in Clorox Co Del (CLX) as Shares Declined

December 15, 2017 - By Adrian Mccoy

Charles Akre increased its stake in Monro Muffler Brake Inc (MNRO) by 1.57% based on its latest 2017Q2 regulatory filing with the SEC. Akre Capital Management Llc bought 25,070 shares as the company’s stock declined 12.59% while stock markets rallied. The hedge fund run by Charles Akre held 1.62 million shares of the consumer services company at the end of 2017Q2, valued at $67.75M, up from 1.60 million at the end of the previous reported quarter. Akre Capital Management Llc who had been investing in Monro Muffler Brake Inc for a number of months, seems to be bullish on the $1.69B market cap company. The stock increased 0.98% or $0.5 during the last trading session, reaching $51.55. About 71,425 shares traded. Monro, Inc. (NASDAQ:MNRO) has declined 18.88% since December 15, 2016 and is downtrending. It has underperformed by 35.58% the S&P500.

National Planning Corp decreased its stake in Clorox Co Del (CLX) by 45.36% based on its latest 2017Q2 regulatory filing with the SEC. National Planning Corp sold 2,696 shares as the company’s stock declined 1.16% while stock markets rallied. The institutional investor held 3,248 shares of the specialty chemicals company at the end of 2017Q2, valued at $434,000, down from 5,944 at the end of the previous reported quarter. National Planning Corp who had been investing in Clorox Co Del for a number of months, seems to be less bullish one the $19.07B market cap company. The stock increased 1.12% or $1.64 during the last trading session, reaching $147.9. About 271,584 shares traded. The Clorox Company (NYSE:CLX) has risen 1.68% since December 15, 2016 and is uptrending. It has underperformed by 15.02% the S&P500.

Since August 1, 2017, it had 0 insider purchases, and 2 selling transactions for $3.15 million activity. 64,619 shares were sold by GROSS ROBERT G, worth $3.05M.

Investors sentiment decreased to 1.22 in Q2 2017. Its down 0.23, from 1.45 in 2017Q1. It turned negative, as 31 investors sold MNRO shares while 47 reduced holdings. 31 funds opened positions while 64 raised stakes. 33.30 million shares or 2.32% less from 34.09 million shares in 2017Q1 were reported. Btim Corporation reported 0.2% in Monro, Inc. (NASDAQ:MNRO). Teachers Retirement Of The State Of Kentucky holds 0.01% or 10,300 shares in its portfolio. Retail Bank Of America Corporation De has 296,151 shares. 164,695 are owned by Kornitzer Capital Ks. California-based Fdx Advsrs Inc has invested 0.03% in Monro, Inc. (NASDAQ:MNRO). Gamco Et Al invested 0.02% of its portfolio in Monro, Inc. (NASDAQ:MNRO). 251,209 are owned by Morgan Stanley. First Mercantile Tru holds 0.05% of its portfolio in Monro, Inc. (NASDAQ:MNRO) for 7,030 shares. Alliancebernstein Lp stated it has 0% in Monro, Inc. (NASDAQ:MNRO). Airain Limited stated it has 24,411 shares. Blackrock Inc invested in 4.09M shares or 0.01% of the stock. Qs Limited Liability Corporation stated it has 7 shares. Fifth Third Financial Bank reported 0% stake. Prudential invested 0% in Monro, Inc. (NASDAQ:MNRO). Bank Of Ny Mellon invested in 510,590 shares or 0.01% of the stock.

Among 12 analysts covering Monro Muffler Brake (NASDAQ:MNRO), 4 have Buy rating, 0 Sell and 8 Hold. Therefore 33% are positive. Monro Muffler Brake had 25 analyst reports since August 5, 2015 according to SRatingsIntel. The company was initiated on Monday, September 28 by CL King. The company was initiated on Thursday, December 17 by Goldman Sachs. The firm has “Sector Weight” rating by KeyBanc Capital Markets given on Wednesday, August 19. The stock of Monro, Inc. (NASDAQ:MNRO) has “Hold” rating given on Tuesday, October 24 by KeyBanc Capital Markets. As per Tuesday, October 20, the company rating was initiated by Sterne Agee CRT. The stock of Monro, Inc. (NASDAQ:MNRO) has “Hold” rating given on Wednesday, August 5 by Evercore. Gabelli initiated Monro, Inc. (NASDAQ:MNRO) rating on Tuesday, December 8. Gabelli has “Hold” rating and $72 target. Oppenheimer maintained the shares of MNRO in report on Thursday, July 20 with “Buy” rating. Jefferies maintained it with “Buy” rating and $86 target in Friday, October 23 report. On Wednesday, April 6 the stock rating was maintained by Goldman Sachs with “Neutral”.

Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.01, from 0.96 in 2017Q1. It fall, as 38 investors sold CLX shares while 261 reduced holdings. 65 funds opened positions while 219 raised stakes. 88.17 million shares or 0.11% less from 88.27 million shares in 2017Q1 were reported. Moreover, Ameriprise has 0.09% invested in The Clorox Company (NYSE:CLX) for 1.34 million shares. Eads Heald Investment Counsel owns 10,557 shares. Sumitomo Mitsui Tru Holdg Incorporated, Japan-based fund reported 434,038 shares. Fmr Lc has 106,828 shares. Hanson Doremus Invest reported 0.01% in The Clorox Company (NYSE:CLX). Pensionfund Dsm Netherlands has invested 0.52% in The Clorox Company (NYSE:CLX). Laffer Invests reported 15,485 shares or 0% of all its holdings. Oppenheimer Asset Mngmt Inc owns 24,390 shares for 0.09% of their portfolio. X Commerce Limited Company, New York-based fund reported 5,660 shares. Great Lakes Ltd Company holds 5,970 shares or 0.02% of its portfolio. Private Advisor Grp Limited Liability Com holds 0.09% or 24,407 shares in its portfolio. Pettee Invsts owns 20,000 shares or 2.37% of their US portfolio. Public Sector Pension Inv Board invested 0.02% in The Clorox Company (NYSE:CLX). Verition Fund Ltd Liability invested 0.02% of its portfolio in The Clorox Company (NYSE:CLX). Hartford Mgmt invested in 0.07% or 28,006 shares.

Analysts await The Clorox Company (NYSE:CLX) to report earnings on February, 2. They expect $1.22 earnings per share, down 2.40% or $0.03 from last year’s $1.25 per share. CLX’s profit will be $157.30 million for 30.31 P/E if the $1.22 EPS becomes a reality. After $1.46 actual earnings per share reported by The Clorox Company for the previous quarter, Wall Street now forecasts -16.44% negative EPS growth.

Among 15 analysts covering The Clorox Company (NYSE:CLX), 3 have Buy rating, 2 Sell and 10 Hold. Therefore 20% are positive. The Clorox Company had 43 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Hold” rating by RBC Capital Markets on Friday, October 6. RBC Capital Markets maintained The Clorox Company (NYSE:CLX) on Tuesday, September 5 with “Hold” rating. The rating was maintained by Deutsche Bank on Wednesday, August 5 with “Hold”. On Tuesday, November 15 the stock rating was reinitiated by Wells Fargo with “Market Perform”. The stock of The Clorox Company (NYSE:CLX) earned “Hold” rating by Jefferies on Thursday, August 3. Morgan Stanley maintained The Clorox Company (NYSE:CLX) rating on Thursday, November 2. Morgan Stanley has “Equal-Weight” rating and $128 target. BMO Capital Markets maintained the shares of CLX in report on Tuesday, October 3 with “Buy” rating. BMO Capital Markets maintained it with “Buy” rating and $15000 target in Thursday, August 3 report. The company was initiated on Tuesday, June 14 by Atlantic Securities. Barclays Capital maintained the shares of CLX in report on Wednesday, October 7 with “Underweight” rating.

Since August 23, 2017, it had 0 buys, and 3 sales for $2.94 million activity. On Tuesday, August 29 the insider Willoughby Dawn C sold $297,804. 9,223 shares were sold by Balousek Jon M, worth $1.28 million on Wednesday, August 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>